Globofarm International Private Limited

Globofarm International Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51909MH2020PTC337865 Incorporated 17 February 2020 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma DPIIT Startup MSME · Small
Data last updated
Revenue · FY 2026
₹29.28 Cr
▲ 20% YoY
Net profit · FY 2026
₹36.47 Lakh
Net margin 1.2%
EBITDA · FY 2026
₹1.31 Cr
EBITDA margin 4.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹7.9 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings

About Globofarm International Private Limited

Data last updated:

Globofarm International Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 February 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC337865. Its GSTIN is 27AAICG2350A1Z3 (Maharashtra). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gronil Sanjay Jain and Anushree Jain.

Its last annual general meeting (AGM) was held on 28 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2026, the company reported a revenue of ₹29.28 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹36.47 Lakh (net margin 1.2%) and EBITDA of ₹1.31 Cr (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 22% over five years.

The company is associated with 2 brands: Global Pharma Regulatory Consultancy and Globofarm International. As per MCA filings, the company has open charges of ₹7.9 Cr on record. Court records list 55 cases involving the company, including 17 filed by the company and 38 filed against it; 38 cases are pending.

Globofarm International Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0007667). For more details, the company can be reached via its website globofarm.net.

Company details

CIN U51909MH2020PTC337865
Registration Number 337865
Incorporation Date 17 February 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2026
Date of Balance Sheet 31 March 2026
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-MH-18-0007667

Recognitions & Rankings of Globofarm International

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-18-0007667

Contact details

Globofarm International Private Limited's registered office is in Mumbai, Maharashtra. Its website is globofarm.net. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    602 Silver Square Plot No. 5A Tps II, Dattatray Road Santacruz Bhd Surya Hospital, Mumbai, Maharashtra, India – 400054
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Globofarm International Private Limited, buy the company report.

Comprehensive company report
Globofarm International Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Globofarm International operates two associated brands: Global Pharma Regulatory Consultancy and Globofarm International. Each brand links to its own profile.

BrandDescriptionWebsite
Offers consulting services for pharmaceutical regulatory support.globalpharmaregulatory.com
Manufactures and supplies pharmaceutical ingredients and wellness products worldwide.globofarm.net

Business activity

The main business activity of Globofarm International is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Globofarm International Private Limited, buy the company report.

Financials of Globofarm International Private Limited

FY 2026 filings available

Globofarm International Private Limited reported revenue of ₹29.28 Cr (up 20% YoY) for FY 2026.

Revenue · FY 2026
₹29.28 Cr ▲ 20%
Net profit · FY 2026
₹36.47 Lakh margin 1.2%
EBITDA · FY 2026
₹1.31 Cr margin 4.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 6%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 1%
5 years · compounded
▲ 24%

Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 20% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹29.28 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.31 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹36.47 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin4.5%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Globofarm International Private Limited, buy the company report.

Board of directors of Globofarm International Private Limited

Globofarm International has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Gronil Sanjay JainDirector17 Feb 20206 Years 8 MonthsCurrent
Anushree JainDirector17 Feb 20206 Years 8 MonthsCurrent

Auditor

Globofarm International Private Limited is audited by Mihir Devani & Associates for the financial year 2026.

Auditor firmFinancial yearFirm registration number
Mihir Devani & AssociatesFY 2026150665

Shareholding

The shareholding of Globofarm International Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2025FY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Globofarm International Private Limited, buy the company report.

Charges & borrowings

Open charges
₹7.9 Cr
Satisfied charges
None
Breakdown by lending institutions
Standard Chartered Bank₹7.90 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Aug 2025101146126Standard Chartered Bank₹7.9 CrOpen

Total charge records: 1 View all charges

MSME payment delays

Globofarm International Private Limited has 6 MSME Form 1 returns on record between 2022 and 2024, listing 63 overdue payments to 26 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 26)

SupplierAmount dueDue sinceReported on
Smilax Laboratories Limited
an individual supplier
Valiant Laboratories Limited
Ruskin Chemi Pharma
Precision Adhesive Tapes Private Limited

To see the full MSME payment records of Globofarm International Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Globofarm International has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAICG2350A1Z3MaharashtraActive17 Mar 2020

To see the full GST registrations and return filing status of Globofarm International Private Limited, buy the company report.

Recent activity

Globofarm International Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Anushree Jain was appointed as Director on 17 Feb 2020.

AGM
Globofarm International Private Limited last Annual general meeting of members was held on 28 Sep 2026 as per latest MCA records.
Filing
Globofarm International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Charges
A charge with Standard Chartered Bank amounted to Rs. 790.00 Lakh with Charge ID 101146126 was registered on 18 Aug 2025.
Appointed
Anushree Jain was appointed as Director.
Appointed
Gronil Sanjay Jain was appointed as Director.
Incorporation
17 Feb 2020
Globofarm International Private Limited was registered on 17 Feb 2020 with Roc Mumbai I & aged 6 years 8 months as per MCA records.

Frequently asked questions

Globofarm International is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 February 2020 (6+ years old) and is registered under CIN U51909MH2020PTC337865.

Globofarm International has 2 current directors:

The latest financial statements of Globofarm International on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 28 September 2026. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Globofarm International is 27AAICG2350A1Z3, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Globofarm International is U51909MH2020PTC337865. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Globofarm International has 55 court cases on record: 17 filed by the company and 38 filed against it. 38 are pending.

Globofarm International was incorporated on 17 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.

Anushree Jain was appointed as Director on 17 Feb 2020. Gronil Sanjay Jain was appointed as Director on 17 Feb 2020.

Yes, Globofarm International is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Globofarm International is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0007667).

Globofarm International has 6 MSME Form 1 returns on record between 2022 and 2024, listing 63 overdue payments to 26 micro and small suppliers. The latest return was filed on 30 Apr 2024.